The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Abstract
Application of natural product-based nanoformulations for the treatment of different human diseases, such as cancer, is an emerging field. The conventional cancer therapeutic modalities, including surgery, chemotherapy, immunotherapy, radiotherapy has limited achievements. A larger number of drawbacks are associated with these therapies, including damage to proliferating healthy tissues, structural deformities, systemic toxicity, long-term side effects, resistance to the drug by tumor cells, and psychological problems. The advent of nanotechnology in cancer therapeutics is recent; however, it has progressed and transformed the field of cancer treatment at a rapid rate. Nanotherapeutics have promisingly overcome the limitations of conventional drug delivery system, i.e., low aqueous solubility, low bioavailability, multidrug resistance, and non-specificity. Specifically, natural product-based nanoformulations are being intentionally studded in different model systems. Where it is found that these nanoformulations has more proximity and reduced side effects. The nanoparticles can specifically target tumor cells, enhancing the specificity and efficacy of cancer therapeutic modalities which in turn improves patient response and survival. The integration of phytotherapy and nanotechnology in the clinical setting may improve pharmacological response and better clinical outcome of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–227 of 227
Jabri, T., Imran, M., Aziz, A., Rao, K., Kawish, M., Irfan, M., Malik, M. I., Sımjee, S. U., Arfan, M., & Shah, M. R. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1550091 · Cited by 47
Ahmad, M. Z., Akhter, S., Anwar, M., Kumar, A., Rahman, M., Talasaz, A. H., & Ahmad, F. J. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.719906 · Cited by 44
Duraipandy, N., Lakra, R., Srivatsan, K. V., Samanta, D., Purna Sai, K., & Kiran, M. S. (2014) · Metallomics · doi:10.1039/c4mt00165f · Cited by 43
Nguyen, N. T., Nguyen, N. N. T., Tran, N. T. N., Le, P. N., Nguyen, T. B. T., Nguyen, N. H., Bạch, L. G., Doan, V. N., Tran, H. L. B., Lê, V. T., et al. (2018) · Molecules · doi:10.3390/molecules23123347 · Cited by 43
Li, J., Guo, C., Fan, F., Fan, A., Dai, Y., Li, N., Zhao, D., Chen, X., & Lu, Y. (2016) · Scientific Reports · doi:10.1038/srep38787 · Cited by 42
Plant-derived natural products as leads to antitumor drugs
Zhou, Y. F., Zhang, A.-H., Sun, H. J., Yan, G., & Wang, X. (2014) · Plant Science Today · doi:10.14719/pst.2014.1.2.17 · Cited by 41
Petrov, P. D., Yoncheva, K., Gancheva, V. B., Konstantinov, S., & Trzebicka, B. (2016) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.05.010 · Cited by 41
Celastrol As a Pentacyclic Triterpenoid With Chemopreventive Properties
Yadav, P., Jaswal, V., Sharma, A. K., Kashyap, D., Tuli, H. S., Garg, V. K., Das, S. K., & Srinivas, R. (2018) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2017-0035 · Cited by 41
Self-citationLi, X., Zhang, H., Zheng, D., Ding, J., Xu, H., & Sun, W. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77125 · Cited by 38
Ahmad, M. Z., Akhter, S., Ahmad, I., Rahman, M., Anwar, M. F., Jain, G. K., Ahmad, F. J., & Khar, R. K. (2011) · Current Drug Delivery · doi:10.2174/156720111796642327 · Cited by 38
Feng, M., Lx, Z., Zy, Z., Zh, H., & Jp, X. (2017) · PubMed · Cited by 36
Zhao, Q.-S., Hu, L., Wang, Z., Li, Z., Wang, A., & Liu, J. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.10.077 · Cited by 35
Rahman, M., Beg, S., Aziz, A. N., & Swain, S. (2014) · Current Nanomedicine · doi:10.2174/18779123113036660002 · Cited by 34
Liu, L., Qi, X.-J., Zhong, Z., & Zhang, E.-N. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.001 · Cited by 34
The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols
Sak, K. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1258075 · Cited by 34
Self-citationEncinas-Basurto, D., Ibarra, J., Juárez, J., Burboa, M. G., Barbosa, S., Taboada, P., Troncoso‐Rojas, R., & Valdez, M. A. (2017) · Journal of Microencapsulation · doi:10.1080/02652048.2017.1323037 · Cited by 31
Chen, S., Liang, Q., Liu, E., Yu, Z., Sun, L., Ye, J., Shin, M. C., Wang, J., & He, H. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00040e · Cited by 31
Shukla, P., Mathur, V., Kumar, A., et al. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1912 · Cited by 28
Alkaloids: A Source of Anticancer Agents from Nature
Gupta, A. P., Pandotra, P., Kushwaha, M., Khan, S. H., Sharma, R. B., & Gupta, S. (2015) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63462-7.00009-9 · Cited by 27
Novel Approach for the Treatment of Cancer: Theranostic Nanomedicine
Rahman, M., Ahmad, M. Z., Kazmi, I. A., Akhter, S., Kumar, Y., Ahmad, F. J., & Anwar, F. (2012) · Pharmacologia · doi:10.5567/pharmacologia.2012.371.376 · Cited by 26
He, M., Lillian, R., Liu, J., & Chu, C. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35924 · Cited by 26
Peng, J., Fumoto, S., Miyamoto, H., Chen, Y., Kuroda, N., & Nishida, K. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1315687 · Cited by 25
Curcio, M., Mauro, L., Naimo, G. D., Amantea, D., Cirillo, G., Tavano, L., Casaburi, I., Nicoletta, F. P., Alvarez‐Lorenzo, C., & Iemma, F. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.04.057 · Cited by 23
Qiu, N., Cai, L., Xie, D., Wang, G., Wu, W., Zhang, Y., Song, H., Yin, H., & Chen, L. (2010) · Biomedical Materials · doi:10.1088/1748-6041/5/6/065006 · Cited by 19
An evaluation of anti-tumor effect and toxicity of PEGylated ursolic acid liposomes
Wang, Q., Zhao, T., Liu, Y., Xing, S., Li, L., & Gao, D. (2016) · Journal of Nanoparticle Research · doi:10.1007/s11051-016-3339-8 · Cited by 18
Nam, S., Lee, S. Y., Kang, W., & Cho, H. (2018) · Nanomaterials · doi:10.3390/nano8060384 · Cited by 17
Synthesis of protein nanoparticles for drug delivery
Cheng, D., Yong, X., Zhu, T., Qiu, Y., Wang, J., Zhu, H. J., Ma, B., & Xie, J. (2016) · European Journal of BioMedical Research · doi:10.18088/ejbmr.2.2.2016.pp8-11 · Cited by 13
Cited by
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 607
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 563
Self-citationIntrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis
(2021) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2021.01.003 · Cited by 402
Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Mansouri, K., Rasoulpoor, S., Daneshkhah, A., Abolfathi, S., Salari, N., Mohammadi, M., Rasoulpoor, S., & Shabani, S. (2020) · BMC Cancer · doi:10.1186/s12885-020-07256-8 · Cited by 386
Mirzaei, S., Saghari, S., Bassiri, F., Raesi, R., Zarrabi, A., Hushmandi, K., Sethi, G., & Tergaonkar, V. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30759 · Cited by 243
Self-citation
Metadata
- Authors
- Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 69
- Pages
- 5-23
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2967057123
- Cited by
- 390
- References
- 227
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.